Not Specified years
Posted 245 days ago
The Langenau Laboratory at Harvard Medical School and the Massachusetts General Hospital, Boston are recruiting research fellows to study mechanisms of progression and relapse in T and B cell leukemia and rhabdomyosarcoma – a tumor of muscle.
Research will focus on using the zebrafish genetic model, biochemistry, and cross-species bioinformatics approaches to identify novel pathways that drive progression and relapse. Following discoveries made in the zebrafish model, work will continue in characterizing discoveries in human cell culture, primary patient samples, and mouse xenograft studies.
Applicants with advanced skills in in vivo microscopy, mouse xenograft transplantation, stem cell biology, muscle development, leukemia, blood development, bioinformatic analysis, and biochemistry (including ChIP seq) are highly desired. Background in zebrafish development and/or cancer is not required.